2.0
17. März 2016
Ehemaliger Mitarbeiter, mehr als 3 Jahre
Seattle, WA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
- Huge market potential in pharma - Smart, dedicated ppl in engineering - Great collaboration b/w Seattle & New Zealand dev teams
Kontras
- Sales runs the company, chasing the next deal - Constant churn at executive level, both in execs and company direction - Broken promises (bonus program, cost of living raises, stock options) - No work life balance at all if you're a manager